ReachMD

Be part of the knowledge.™

Cardiology

286

LikeLikedUnlike

Episodes 1-15 of 23

- Javed Butler, MD, MPH, MBA
  Peer
- Piotr Ponikowski, MD, PHD, FESC, FHFA
  Peer
- Gerasimos Filippatos, MD, FESC, FHFA
  Peer
3
CME/CE
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
0.25 credits
- Javed Butler, MD, MPH, MBA
  Peer
- Piotr Ponikowski, MD, PHD, FESC, FHFA
  Peer
- Gerasimos Filippatos, MD, FESC, FHFA
  Peer
7
CME/CE
AHA 2020: New Insights on Iron Deficiency and Heart Failure
AHA 2020: New Insights on Iron Deficiency and Heart Failure
0.25 credits
- G. Michael Felker, MD, MHS
  Peer
- Nancy K. Sweitzer, MD, PhD
  Peer
- John R. Teerlink, MD
  Peer
5
CME/CE
Improving Pump Function in Heart Failure with Reduced Ejection Fraction
Improving Pump Function in Heart Failure with Reduced Ejection Fraction
0.50 credits
- Eliot Brinton, MD, FAHA, FNLA
  Peer
- Erin D. Michos, MD, MHS, FACC, FAHA, FASE
  Peer
11
CME/CE Broadcast Replay
The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue
The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue
0.75 credits
- Javed Butler, MD, MPH, MBA
  Peer
- Peter van der Meer, MD, PhD
  Peer
8
CME/CE
Common Misconceptions About Iron Deficiency in Heart Failure and What to Do About It
Common Misconceptions About Iron Deficiency in Heart Failure and What to Do About It
0.25 credits
- George Bakris, MD
  Peer
- Matthew R. Weir, MD
  Peer
- Faiez Zannad, MD, PhD
  Peer
8
CME/CE
Potassium Management Made Easy
Potassium Management Made Easy
0.25 credits
- Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
  Peer
- Mikhail Kosiborod, MD
  Peer
19
CME/CE
Management of Heart Failure: Time to Consider New Options?
Management of Heart Failure: Time to Consider New Options?
0.25 credits
- Michel Farnier, MD, PhD
  Peer
- Børge G. Nordestgaard, MD, DMSc
  Peer
5
CME/CE
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl (IPE)
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl (IPE)
0.75 credits
- Christopher P. Cannon, MD
  Peer
- Samuel Dagogo-Jack, MD, DSc
  Peer
7
CME/CE
Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?
Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?
0.25 credits
- Julio A. Ramírez, MD, FACP
  Peer
- Charles P. Vega, MD
  Peer
4
CME/CE
Selección Apropiada de Terapia Antiviral Contra la Influenza
Selección Apropiada de Terapia Antiviral Contra la Influenza
0.25 credits
- Charles P. Vega, MD
  Peer
- Angel O. Coz Yataco, MD, FCCP
  Peer
7
CME/CE
La Influenza: Ciencia Emergente en Pacientes de Alto Riesgo en la Población
La Influenza: Ciencia Emergente en Pacientes de Alto Riesgo en la Población
0.25 credits
- Javed Butler, MD, MPH, MBA
  Peer
7
CME/CE
Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy
Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy
0.25 credits
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
- Stefan D. Anker, MD, PhD
  Peer
15
CME/CE
Beyond Anemia: Understanding the Significance and Treatment of Iron Deficiency
Beyond Anemia: Understanding the Significance and Treatment of Iron Deficiency
0.25 credits
- Robert J. Mentz, MD
  Peer
- Piotr Ponikowski, MD, PHD, FESC, FHFA
  Peer
15
CME/CE
Don’t Be Fooled: It’s Not Just Anemia, It’s Iron Deficiency
Don’t Be Fooled: It’s Not Just Anemia, It’s Iron Deficiency
0.25 credits
- Sergio Fazio, MD, PhD
  Peer
7
CME/CE
Practical Considerations to Manage Residual ASCVD Risk
Practical Considerations to Manage Residual ASCVD Risk
0.25 credits

Loading...

Programs 1/16/21

Segment Chapters

Playlist:

Recommended